Neurons, Drugs, and Medications
Theories, More Theories, and Theories about Theories
Assessment and the Continuum of Care
Wild Card!
100

Naltrexone, Suboxone, and Methadone can all be used to treat this...

Opioid Use Disorder

100

This term, or “component”, describes the tendency of individuals with substance use disorders to return to addictive behaviors, even when they sincerely are interested in remaining abstinent.

Relapse 

100

This structured interview is quite lengthy, but can be used to objectively determine the appropriate level of care for an individual seeking addiction treatment.

ASAM Criteria 

100

This philosophy of treatment prioritizes the prevention of harmful outcomes, as opposed to strictly enforcing abstinence.

Harm Reduction

200

This term describes a drug or medication that binds to receptors and prevents

other chemicals from interacting with the same receptors, resulting in a net

decrease in signaling.

Antagonist 

200

A clinician who believes that their client began using substances to treat their own preexisting depression might be a fan of this theory.

Self-medication Theory 

200

How efficient! These instruments are used to identify patients who might need more follow-up.

Screeners

200

Many evidence-based treatments for addictions will focus on increasing this trait. It describes a client’s perception of their own ability to face challenges.

Self-efficacy

300

This medication causes an individual to feel sick when they consume alcohol.

Antabuse (disulfiram) 

300

Adverse childhood experiences, impulsivity, and in utero substance exposure all fall under this umbrella term, which lists traits and experiences that people with substance use disorders and other mental health conditions frequently report

Common Factors

300

The model considers both mental health treatment needs and addiction treatment needs to estimate where a client is most likely to be encountered 

Quadrant Model of Dual Diagnosis

300

Evidence-based treatments for addictions that focus on behavior will often utilize this method for shaping behavior.

Reinforcement (reward)

400

Suboxone, or buprenorphine, could be described using this term. It describes

a drug or medication that binds to a receptor and produces a response, but

also blocks other chemicals or medications from binding to it.

Partial Agnoist

400

Clinicians who practice motivational interviewing use this term to describe their clients’ stated reasons for continuing to use substances.

Sustain Talk

400

This form of care is easy to implement, but generic and may leave clients feeling like their individual needs haven’t been addressed.

Program-Centered Care

400

Following a client’s relapse, a clinician might use this strategy to increase the client’s insight surrounding thoughts and feelings before, during, and after the substance use.

Functional Analysis of Substance Use Behavior

500

This term describes the reduced effect of a substance in an individual who has used the substance repeatedly.

Tolerance

500

This is a major goal in motivational interviewing. It involves promoting a non-judgmental environment so a client can reflect on their reasons for drug use and how drug use might conflict with their life goals or values.

Developing Discrepancy 

500

These specialty treatment settings are a form of diversion. Eligible participants have a history of addiction and are usually facing criminal charges or have pled guilty to charges.

Drug Court

500

A drug that has been deemed highly addictive, dangerous, and not medically useful will typically be classified here according to the Comprehensive Drug Abuse Prevention and Control Act of 1970. 

Schedule 1